Reckitt Benckiser Group plc (LON:RKT – Get Free Report) has been assigned an average rating of “Hold” from the seven analysts that are currently covering the company, Marketbeat.com reports. Four research analysts have rated the stock with a hold recommendation and three have assigned a buy recommendation to the company. The average 12 month price target among brokerages that have issued a report on the stock in the last year is GBX 6,204.29.
RKT has been the subject of a number of research analyst reports. Deutsche Bank Aktiengesellschaft decreased their price target on Reckitt Benckiser Group from GBX 5,460 to GBX 5,430 and set a “hold” rating for the company in a research note on Tuesday, April 28th. Berenberg Bank cut their price objective on shares of Reckitt Benckiser Group from GBX 7,000 to GBX 6,200 and set a “buy” rating on the stock in a report on Friday, April 24th. Jefferies Financial Group reaffirmed a “hold” rating and issued a GBX 5,600 price objective on shares of Reckitt Benckiser Group in a research report on Tuesday, May 12th. Royal Bank Of Canada reiterated a “neutral” rating and issued a GBX 6,200 target price on shares of Reckitt Benckiser Group in a research note on Friday, May 15th. Finally, Citigroup cut their price target on shares of Reckitt Benckiser Group from GBX 7,000 to GBX 6,200 and set a “buy” rating on the stock in a research note on Thursday, April 23rd.
Reckitt Benckiser Group Stock Performance
Reckitt Benckiser Group (LON:RKT – Get Free Report) last posted its quarterly earnings data on Thursday, March 5th. The company reported £122.58 earnings per share for the quarter. Reckitt Benckiser Group had a return on equity of 38.45% and a net margin of 25.23%. Analysts expect that Reckitt Benckiser Group will post 331.2110727 earnings per share for the current fiscal year.
Insider Buying and Selling at Reckitt Benckiser Group
In related news, insider Kris Licht sold 5,435 shares of the company’s stock in a transaction on Tuesday, April 28th. The stock was sold at an average price of GBX 4,753, for a total value of £258,325.55. 0.44% of the stock is owned by company insiders.
About Reckitt Benckiser Group
At Reckitt, we protect, heal and nurture. We are the company behind some of the world’s best known and most trusted Health and Hygiene consumer brands.
Delivering for a cleaner, healthier world requires strong brands with a global footprint. From Dettol, Lysol, Durex, Finish, Harpic and Vanish, Mucinex, Nurofen, Gaviscon, Veet and Strepsils, consumers love and rely on our brands to care for their families, as they have done for over 200 years.
We use our scientific expertise and deep human understanding to develop solutions to help people improve their lives – that is why over 30 million Reckitt products are sold each day worldwide.
At Reckitt, we’re all making a real difference to people all over the world, every day.
Further Reading
- Five stocks we like better than Reckitt Benckiser Group
- Banks Are Buying Back Stock Hand Over Fist, Including These 3 Names
- 2 Aluminum Stocks Poised for Big Tariff-Related Gains
- AutoZone’s Pullback Sets Up a Long-Term Buying Opportunity
- AST SpaceMobile’s June Launch Plan Puts Its 2026 Satellite Goal Back in Focus
Receive News & Ratings for Reckitt Benckiser Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Reckitt Benckiser Group and related companies with MarketBeat.com's FREE daily email newsletter.
